Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00628199
Recruitment Status : Unknown
Verified February 2009 by Stanford University.
Recruitment status was:  Enrolling by invitation
First Posted : March 4, 2008
Last Update Posted : February 24, 2009
Information provided by:
Stanford University

Brief Summary:
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Condition or disease Intervention/treatment
Metabolic Diseases Infertility Procedure: Improving the scientific process of human cell reprogramming

Detailed Description:
It is thought that studies of genetic reprogramming and SCNT using human cells have the potential to give us new basic knowledge about human development. Current work will focus on developing this basic knowledge. In the future, human embryonic stem cell lines (hESC) derived from genetic reprogramming and SCNT may also have the potential to develop into cell types that are useful for cell-based therapies to treat human disease and disability.

Study Type : Observational
Estimated Enrollment : 60 participants
Time Perspective: Prospective
Official Title: Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
Study Start Date : September 2007
Estimated Primary Completion Date : January 2010

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   1 Year to 75 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)

Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00628199

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Principal Investigator: Renee A. Reijo Pera Stanford University

Responsible Party: Tasha Kalista, M.A. Identifier: NCT00628199     History of Changes
Obsolete Identifiers: NCT00553826
Other Study ID Numbers: SU-12202007-950
First Posted: March 4, 2008    Key Record Dates
Last Update Posted: February 24, 2009
Last Verified: February 2009

Additional relevant MeSH terms:
Metabolic Diseases
Genital Diseases, Male
Genital Diseases, Female